Activin A expression regulates multipotency of mesenchymal progenitor cells

被引:42
作者
Djouad, Farida [1 ]
Jackson, Wesley M. [1 ]
Bobick, Brent E. [1 ]
Janjanin, Sasa [1 ]
Song, Yingjie [1 ]
Huang, George T. J. [1 ]
Tuan, Rocky S. [1 ]
机构
[1] NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
EMBRYONIC STEM-CELLS; IN-VITRO; DENDRITIC CELLS; GROWTH-FACTOR; SELF-RENEWAL; DIFFERENTIATION; BONE; FOLLISTATIN; TISSUE; PROLIFERATION;
D O I
10.1186/scrt11
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Introduction: Bone marrow (BM) stroma currently represents the most common and investigated source of mesenchymal progenitor cells (MPCs); however, comparable adult progenitor or stem cells have also been isolated from a wide variety of tissues. This study aims to assess the functional similarities of MPCs from different tissues and to identify specific factor(s) related to their multipotency. Methods: For this purpose, we directly compared MPCs isolated from different adult tissues, including bone marrow, tonsil, muscle, and dental pulp. We first examined and compared proliferation rates, immunomodulatory properties, and multidifferentiation potential of these MPCs in vitro. Next, we specifically evaluated activin A expression profile and activin A: follistatin ratio in MPCs from the four sources. Results: The multidifferentiation potential of the MPCs is correlated with activin A level and/or the activin A: follistatin ratio. Interestingly, by siRNA-mediated activin A knockdown, activin A was shown to be required for the chondrogenic and osteogenic differentiation of MPCs. These findings strongly suggest that activin A has a pivotal differentiation-related role in the early stages of chondrogenesis and osteogenesis while inhibiting adipogenesis of MPCs. Conclusions: This comparative analysis of MPCs from different tissue sources also identifies bone marrow-derived MPCs as the most potent MPCs in terms of multilineage differentiation and immunosuppression, two key requirements in cell-based regenerative medicine. In addition, this study implicates the significance of activin A as a functional marker of MPC identity.
引用
收藏
页数:13
相关论文
共 65 条
[1]  
Abe M, 2002, J LEUKOCYTE BIOL, V72, P347
[2]   Mesenchymal stem cells: clinical applications and biological characterization [J].
Barry, FP ;
Murphy, JM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) :568-584
[3]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[4]  
BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261
[5]  
Breit S, 2000, CANCER RES, V60, P4596
[6]   Human marrow-derived mesenchymal progenitor cells - Isolation, culture expansion, and analysis of differentiation [J].
Caterson, E ;
Nesti, L ;
Danielson, KG ;
Tuan, RS .
MOLECULAR BIOTECHNOLOGY, 2002, 20 (03) :245-256
[7]   Regulation of cell proliferation, apoptosis, and carcinogenesis by activin [J].
Chen, YG ;
Lui, HM ;
Lin, SL ;
Lee, JM ;
Ying, SY .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (02) :75-87
[8]  
De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO
[9]  
2-P
[10]   Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation [J].
Derfoul, A. ;
Miyoshi, A. D. ;
Freeman, D. E. ;
Tuan, R. S. .
OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (06) :646-655